logo

IDXX

IDEXX Laboratories·NASDAQ
--
--(--)
--
--(--)
9.18 / 10
Outperform

Fundamental analysis rates IDXX as Outperform (9.2/10). Profit‑MV, Cash‑MV, ROA and profit margins rank in top quartiles, driving a favorable outlook. Asset‑MV and Total‑profit/EBIT lag, but overall composition remains highly attractive.

Fundamental(9.18)SentimentTechnical

Analysis Checks(8/10)

ROA (%)
Value31.89
Score3/3
Weight14.24%
1M Return0.90%
Net cash flow from operating activities / Operating revenue (%)
Value27.46
Score3/3
Weight29.55%
1M Return1.78%
Profit-MV
Value0.08
Score2/3
Weight20.95%
1M Return1.31%
Net profit margin (%)
Value24.62
Score3/3
Weight13.08%
1M Return0.82%
Total profit / EBIT (%)
Value97.36
Score1/3
Weight-33.53%
1M Return-2.58%
Net cash flow from operating activities / Total liabilities (%)
Value0.68
Score3/3
Weight22.83%
1M Return1.42%
Annualized net profit margin on total assets (%)
Value31.89
Score3/3
Weight14.24%
1M Return0.90%
Asset-MV
Value-0.55
Score0/3
Weight-45.26%
1M Return-3.39%
Cash-MV
Value-1.01
Score2/3
Weight45.66%
1M Return2.64%
Net profit / Total profit (%)
Value80.01
Score3/3
Weight18.25%
1M Return1.16%
Is IDXX fundamentally strong?
  • IDXX scores 9.18/10 on fundamentals and holds a Discounted valuation at present. Backed by its 66.20% ROE, 24.62% net margin, 42.85 P/E ratio, 28.28 P/B ratio, and 22.28% earnings growth, these metrics solidify its Outperform investment rating.